These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2022593)

  • 21. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma.
    Gill PS; Mitsuyasu RT; Montgomery T; Huang J; Cabriales S; Testa M; Espina BM; Levine AM; Miles SA
    Cancer J Sci Am; 1997; 3(5):278-83. PubMed ID: 9327151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of recombinant interferons and hematopoietic growth factors in patients infected with human immunodeficiency virus.
    Mitsuyasu RT
    Rev Infect Dis; 1991; 13(5):979-84. PubMed ID: 1720567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma.
    Scadden DT; Bering HA; Levine JD; Bresnahan J; Evans L; Epstein C; Groopman JE
    J Clin Oncol; 1991 May; 9(5):802-8. PubMed ID: 2016623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of GM-CSF in AIDS.
    Scadden DT
    Infection; 1992; 20 Suppl 2():S103-6. PubMed ID: 1283604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Open-label phase I study of combination therapy with zidovudine and interferon-beta in patients with AIDS-related Kaposi's sarcoma: AIDS Clinical Trials Group Protocol 057.
    Miles S; Levine A; Feldstein M; Carden J; Cabriallas S; Marcus S; Mitsuyasu R; Gill P
    Cytokines Cell Mol Ther; 1998 Mar; 4(1):17-23. PubMed ID: 9557213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, placebo-controlled trial of granulocyte-macrophage colony-stimulating factor and nucleoside analogue therapy in AIDS.
    Brites C; Gilbert MJ; Pedral-Sampaio D; Bahia F; Pedroso C; Alcantara AP; Sasaki MD; Matos J; Renjifo B; Essex M; Whitmore JB; Agosti JM; Badaro R
    J Infect Dis; 2000 Nov; 182(5):1531-5. PubMed ID: 11023477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine.
    Miles SA; Mitsuyasu RT; Moreno J; Baldwin G; Alton NK; Souza L; Glaspy JA
    Blood; 1991 May; 77(10):2109-17. PubMed ID: 1709368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of GM-CSF in patients with AIDS: a review of the literature.
    Ross SD; DiGeorge A; Connelly JE; Whiting GW; McDonnell N
    Pharmacotherapy; 1998; 18(6):1290-7. PubMed ID: 9855329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
    Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biology and clinical applications of GM-CSF].
    Robak T
    Acta Haematol Pol; 1994; 25(2):99-109. PubMed ID: 8067193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GM-CSF as an alternative to dose modification of the combination zidovudine and interferon-alpha in the treatment of AIDS-associated Kaposi's sarcoma.
    Scadden DT; Bering HA; Levine JD; Bresnahan J; Evans L; Epstein C; Groopman JE
    Am J Clin Oncol; 1991; 14 Suppl 1():S40-4. PubMed ID: 2048563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC; Pantanowitz L; Dezube BJ
    Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of AIDS and its attendant malignancies.
    Volberding PA; Kaplan LD
    Prog Clin Biol Res; 1989; 288():459-70. PubMed ID: 2654959
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of hematopoietic hormones for bone marrow defects in AIDS.
    Aboulafia DM
    Oncology (Williston Park); 1997 Dec; 11(12):1827-34, 1839, 1843-4; discussion 1. PubMed ID: 9436189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro enhancement of erythropoiesis by steel factor in Diamond-Blackfan anemia and treatment of other congenital cytopenias with recombinant interleukin 3/granulocyte-macrophage colony stimulating factor.
    Sieff C; Guinan E
    Stem Cells; 1993 Jul; 11 Suppl 2():113-22. PubMed ID: 7691316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic growth factors.
    Williams ME; Quesenberry PJ
    Hematol Pathol; 1992; 6(3):105-24. PubMed ID: 1429340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematopoietic growth factors in AIDS.
    Groopman JE; Feder D
    Semin Oncol; 1992 Aug; 19(4):408-14. PubMed ID: 1380730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
    Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
    Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.